“In the last week of the quarter, we re-initiated a position in PTTEP TB (1.5%), a new holding in BCP TB (1.5%) and MEDC IJ (4.5%), increased our weighting in HIBI MK from 4% to 6%, and VEB MK from 3% to 5%, and exited PGAS IJ (2%) to fund these positions.”
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.